eli lilly zepbound tirzepatide Lilly's in shortage months after approval Eli Lilly - Zepbound (tirzepatide)

Neuroscience Professor & Host, Huberman Lab Podcast Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the department of Neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine

10.1016/s0896-6273(04)00048-0 Summary Keywords tirzepatide, diabetes mellitus, spatial learning and memory, A, synaptic plasticity, inflammation, insulin Citation Guo X, Lei M, Zhao J, Wu M, Ren Z, Yang X, Ouyang C, Liu X, Liu C and Chen Q (2023) Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats

doi: 10.1016/j.jbc.2022.102401, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 116

Changes in Body Weight at Week 68 in Study 6 in East-Asian Patients (WEGOVY 1.7 mg) LSMean = least squares mean

The program is $299 every five weeks for semaglutide doses under .2 mg and includes all medication and care